Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens

  • Mourenza Flórez, Álvaro
  • Lorente Torres, Blanca
  • Durante, Elena
  • Llano Verdeja, Jesús
  • Aparicio Fernández, Jesús Manuel
  • Fernández López, Arsenio
  • Gil Santos, José Antonio
  • Mateos Delgado, Luis Mariano
  • Letek Polberg, Michal
[EN] The development of RNA-based anti-infectives has gained interest with the successful application of mRNA-based vaccines. Small RNAs are molecules of RNA of <200 nucleotides in length that may control the expression of specific genes. Small RNAs include small interference RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), or microRNAs (miRNAs). Notably, the role of miRNAs on the post-transcriptional regulation of gene expression has been studied in detail in the context of cancer and many other genetic diseases. However, it is also becoming apparent that some human miRNAs possess important antimicrobial roles by silencing host genes essential for the progress of bacterial or viral infections. Therefore, their potential use as novel antimicrobial therapies has gained interest during the last decade. The challenges of the transport and delivery of miRNAs to target cells are important, but recent research with exosomes is overcoming the limitations in RNA-cellular uptake, avoiding their degradation. Therefore, in this review, we have summarised the latest developments in the exosomal delivery of miRNA-based therapies, which may soon be another complementary treatment to pathogen-targeted antibiotics that could help solve the problem caused by multidrug-resistant bacteria, SI, We thank the Junta de Castilla y León (Spain) for funding our research work on microRNAs, grant number LE044P20. A.M. is supported with a postdoctoral fellowship “Margarita Salas”. M.L. is the recipient of a “Beatriz Galindo” grant (Ref. BEAGAL18/00068 - BGP18/00033)
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens

  • Lorente Torres, Blanca
  • Llano Verdeja, Jesús
  • Castañera Estrada, Pablo
  • Álvarez Ferrero, Helena
  • Fernández Martínez, Sergio 2002-
  • Javadimarand, Farzaneh
  • Mateos Delgado, Luis Mariano
  • Letek Polberg, Michal
  • Mourenza Flórez, Álvaro
This article belongs to the Special Issue Alternative Approaches to Treating Antimicrobial Resistant Infections, 3rd Edition, [EN] Intracellular bacterial pathogens pose significant public health challenges due to their ability to evade immune defenses and conventional antibiotics. Drug repurposing has recently been explored as a strategy to discover new therapeutic uses for established drugs to combat these infections. Utilizing high-throughput screening, bioinformatics, and systems biology, several existing drugs have been identified with potential efficacy against intracellular bacteria. For instance, neuroleptic agents like thioridazine and antipsychotic drugs such as chlorpromazine have shown effectiveness against Staphylococcus aureus and Listeria monocytogenes. Furthermore, anticancer drugs including tamoxifen and imatinib have been repurposed to induce autophagy and inhibit bacterial growth within host cells. Statins and anti-inflammatory drugs have also demonstrated the ability to enhance host immune responses against Mycobacterium tuberculosis. The review highlights the complex mechanisms these pathogens use to resist conventional treatments, showcases successful examples of drug repurposing, and discusses the methodologies used to identify and validate these drugs. Overall, drug repurposing offers a promising approach for developing new treatments for bacterial infections, addressing the urgent need for effective antimicrobial therapies, SI, We would like to extend our heartfelt thanks for the grant CNS2022-135378 funded by MCIN/AEI/10.13039/501100011033 and by European Union NextGenerationEU/PRTR; to the Junta de Castilla y León (JCyL), Spain, for funding our research through the grant LE044P20, and acknowledge the fellowships that have supported our team: B.L.-T. received a predoctoral fellowship from the JCyL; J.L.-V. and H.Á.F. earned the Beca de Colaboración from the Spanish Ministry of Education, with J.L.-V. also securing an FPU fellowship (FPU2022-00432); P.C. was awarded a Ph.D. fellowship by ULE; S.F.-M. was awarded with AECC summer scholarship; Á.M. received a Margarita Salas postdoctoral fellowship and M.L. was recipient of a Beatriz Galindo grant (ref. BEAGAL18/00068—BGP18/00033)
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Novel Treatments and Preventative Strategies Against Food-Poisoning Caused by Staphylococcal Species

  • Mourenza Flórez, Álvaro
  • Gil Santos, José Antonio
  • Mateos Delgado, Luis Mariano
  • Letek Polberg, Michal
This article belongs to the Special Issue Virulence Factors, Enterotoxin Production and Antibiotic Resistance of Staphylococci Isolated from Food, [EN] Staphylococcal infections are a widespread cause of disease in humans. In particular, S. aureus is a major causative agent of infection in clinical medicine. In addition, these bacteria can produce a high number of staphylococcal enterotoxins (SE) that may cause food intoxications. Apart from S. aureus, many coagulase-negative Staphylococcus spp. could be the source of food contamination. Thus, there is an active research work focused on developing novel preventative interventions based on food supplements to reduce the impact of staphylococcal food poisoning. Interestingly, many plant-derived compounds, such as polyphenols, flavonoids, or terpenoids, show significant antimicrobial activity against staphylococci, and therefore these compounds could be crucial to reduce the incidence of food intoxication in humans. Here, we reviewed the most promising strategies developed to prevent staphylococcal food poisoning, SI, We want to thank the Junta de Castilla y León (Spain) for funding our research work (Ref. LE044P20)
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Drug Repurposing: A Quick and Easy Way of Finding New Medicines

  • Mourenza Flórez, Álvaro
  • Bravo-Santano, Natalia
  • Gil Santos, José Antonio
  • Mateos Delgado, Luis Mariano
  • Letek Polberg, Michal
[EN] Every year, we face infectious outbreaks produced by harmful microorganisms commonly called superbugs. Often, there is not enough time to find new treatments to cure infected patients. On average, it takes a decade to develop a promising new drug to the point where it can be used on patients! Also, many of the compounds that we identify in the laboratory as promising anti-infectives are not useful for treating patients, mainly because they have unexpected, unsafe side effects. However, researchers have already found thousands of drugs that can safely be used to treat specific diseases. These compounds are approved to be used on patients for particular illnesses, but many of them have not been tested to treat any other diseases. Some of these drugs could be repurposed to treat infections caused by new superbugs. In this article, we summarize some exciting strategies used to find new anti-infectives by drug repurposing, SI, We want to thank the Junta de Castilla y León (Spain) for funding our research work on drug repurposing (Ref. LE044P20)